Syneos Health, Inc. Class A Common Stock
SYNH
SYNH was delisted on the 27th of September, 2023.
232 hedge funds and large institutions have $2.48B invested in Syneos Health, Inc. Class A Common Stock in 2017 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 87 increasing their positions, 82 reducing their positions, and 44 closing their positions.
125% more call options, than puts
Call options by funds: $8.17M | Put options by funds: $3.63M
6% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 82
5% less funds holding
Funds holding: 245 → 232 (-13)
11% less capital invested
Capital invested by funds: $2.78B → $2.48B (-$304M)
11% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 44
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$176M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$42M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$32M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$31.5M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$28.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$50.9M |
| 2 |
PIP
Permian Investment Partners
Dallas,
Texas
|
-$43.1M |
| 3 |
BAMCO Inc
New York
|
-$27.4M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$26M |
| 5 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$25.1M |
SYNH Hedge Fund Activity: Q1 2017 in Review
232 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Syneos Health, Inc. Class A Common Stock (SYNH) for Q1 2017, worth a combined $2.48B — down 11% from $2.78B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of SYNH and 39 opened new positions — a net loss of 5 holders — while 82 trimmed existing stakes and 87 added.
The largest buyer was BlackRock, adding an estimated $176M. The largest seller was Marshall Wace, exiting entirely with an estimated $50.9M sold.
- 232 institutional investors held Syneos Health, Inc. Class A Common Stock (SYNH) as of Q1 2017, down from 245 in Q4 2016.
- Funds reported $2.48B of Syneos Health, Inc. Class A Common Stock stock for Q1 2017, down 11% quarter-over-quarter.
- 39 funds opened new Syneos Health, Inc. Class A Common Stock positions in Q1 2017 and 44 closed out, a net change of -5 holders.
- The largest Syneos Health, Inc. Class A Common Stock buyer in Q1 2017 was BlackRock, an estimated $176M added.
- The largest Syneos Health, Inc. Class A Common Stock seller in Q1 2017 was Marshall Wace, an estimated $50.9M sold.
Based on aggregated 13F filings for Q1 2017.